1、Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis" y3 G' u- `; c" p& G. R4 j
http://www.ncbi.nlm.nih.gov/pubmed/8388741 * @) _- d1 q* d' D2、Tissue factor antigen levels in various biological fluids! I3 G2 x8 i! B
http://www.ncbi.nlm.nih.gov/pubmed/7647218" h& D' F3 l7 ]/ f 3、Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers.4 s. Y N' X) l- M. g! s0 A8 G
http://www.ncbi.nlm.nih.gov/pubmed?term=Vascular%20endothelial%20growth%20factor%20(VEGF-A)%20plasma%20levels%20in%20non-small%20cell%20lung%20cancer%3A%20relationship%20with%20coagulation%20and%20platelet%20activation%20markers. E2 h" e7 U9 h9 T 4、The changes of blood coagulation in surgical patients with lung cancer7 w: D; [2 O9 Y; k% d4 ]8 p
http://www.ncbi.nlm.nih.gov/pubmed?term=The%20changes%20of%20blood%20coagulation%20in%20surgical%20patients%20with%20lung%20cancer
发表于 2011-8-8 12:15
